08 January 2025 : Clinical Research
Predictive Factors for Post-Thrombotic Syndrome in Patients with Deep Vein Thrombosis Treated with AngioJet Pharmacomechanical Thrombectomy: A Retrospective Single-Center Study
Xing Li BDE 1, Yun Huang DE 2, Huoqi Liang CF 1, Chongjun Zhong BCF 1, Zhibing Ming AG 1*DOI: 10.12659/MSM.944805
Med Sci Monit 2025; 31:e944805
Table 2 Clinical outcomes for patients with post-thrombotic syndrome (group A) and without post-thrombotic syndrome (group B).
| Variables | Group A (n=22) | Group B (n=67) | P value |
|---|---|---|---|
| Dosage of thrombolytic agents (median, [IQR], million unit) | 260, [80] | 300, [80] | 0.210 |
| Duration of hospital stays (median, [IQR], d) | 6, [5.5] | 5, [4] | 0.542 |
| Minor bleeding (n, %) | 2, 2.24% | 4, 4.49% | 0.878 |
| Villalta score (median, [IQR]) | 7, [3] | 2, [2] | <0.001 |
| Vessel patency (n) | 0.016 | ||
| Grade I | 7 | 11 | |
| Grade II | 12 | 29 | |
| Grade III | 3 | 27 | |